Evidence map›Paper›PMID 32670604›Full record

ArticleFuture science OA2020

A rapid high-throughput sequencing-based approach for the identification of unknown bacterial pathogens in whole blood.

Ofir Israeli, Efi Makdasi, Inbar Cohen-Gihon, Anat Zvi, Shirley Lazar, Ohad Shifman, Haim Levy, David Gur, Orly Laskar, Adi Beth-Din

Abstract read
In one paragraph

Article in Future science OA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ofir IsraeliDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.ORCID https://orcid.org/0000-0002-4590-6151
Efi MakdasiDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Inbar Cohen-GihonDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Anat ZviDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Shirley LazarDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Ohad ShifmanDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Haim LevyDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
David GurDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
Orly LaskarDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Adi Beth-DinDepartment of Biochemistry & Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput DNA sequencing (HTS) of pathogens in whole blood samples is hampered by the high host/pathogen nucleic acids ratio. We describe a novel and rapid bacterial enrichment procedure whose implementation is exemplified in simulated bacteremic human blood samples. The procedure involves depletion of the host DNA, rapid HTS and bioinformatic analyses. Following this procedure,

Indexed as

bacteremiaB. anthracisF. tularensishigh-throughput DNA sequencinghost/pathogen DNA ratiowhole blood samplesY. pestis

Identifiers

PMID32670604
PMCPMC7351085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.